Merck Life Science KGaA News and Resources

Merck, a science and technology company, has entered into a definitive agreement to acquire HUB Organoids Holding B.V., a Netherlands-based pioneer in organoid technology. The acquisition aims to enhance Merck’s expertise in next-generation biology and drug discovery. Terms of the